SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,000 | – | 17 | +6.2% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 16 | -93.5% | 0.00% | – |
Q1 2022 | $8,000 | 0.0% | 245 | -16.1% | 0.00% | – |
Q3 2021 | $8,000 | 0.0% | 292 | +12.7% | 0.00% | – |
Q2 2021 | $8,000 | -84.0% | 259 | -86.5% | 0.00% | -100.0% |
Q1 2021 | $50,000 | -51.0% | 1,919 | -61.2% | 0.00% | -57.1% |
Q3 2020 | $102,000 | +264.3% | 4,946 | +503.9% | 0.01% | +250.0% |
Q1 2019 | $28,000 | -6.7% | 819 | -6.9% | 0.00% | -33.3% |
Q4 2018 | $30,000 | +328.6% | 880 | +511.1% | 0.00% | +200.0% |
Q3 2018 | $7,000 | -100.0% | 144 | -40.0% | 0.00% | 0.0% |
Q2 2018 | $14,364,000 | +26016.4% | 240 | -79.9% | 0.00% | -80.0% |
Q1 2018 | $55,000 | -45.0% | 1,192 | -52.7% | 0.01% | -37.5% |
Q4 2017 | $100,000 | +9.9% | 2,521 | +11.0% | 0.01% | -20.0% |
Q3 2017 | $91,000 | -11.7% | 2,272 | -4.6% | 0.01% | 0.0% |
Q2 2017 | $103,000 | +5050.0% | 2,382 | +3455.2% | 0.01% | – |
Q1 2017 | $2,000 | -95.7% | 67 | -97.1% | 0.00% | -100.0% |
Q2 2016 | $47,000 | -88.1% | 2,307 | -91.1% | 0.00% | -89.2% |
Q1 2016 | $394,000 | +13.5% | 25,816 | 0.0% | 0.04% | +19.4% |
Q4 2015 | $347,000 | -49.7% | 25,816 | -47.5% | 0.03% | -54.4% |
Q3 2015 | $690,000 | – | 49,167 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |